These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A few specialty drug prices fall--all generics. Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766 [No Abstract] [Full Text] [Related]
24. Market watch: Sales of biologics to show robust growth through to 2013. Goodman M Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035 [No Abstract] [Full Text] [Related]
25. IP litigation in China could drive innovation. Jia H Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539 [No Abstract] [Full Text] [Related]
26. SuperGenerics: a better alternative for biogenerics. Charles SA Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591 [No Abstract] [Full Text] [Related]
27. White paper. The five myths of generic competition. A Pharma Matters report. March 2009. Drug News Perspect; 2009 Apr; 22(3):171-5. PubMed ID: 19440560 [TBL] [Abstract][Full Text] [Related]
28. Overcoming further challenges in the pharma/biotech industry: 2007 update. Graul AI; Cruces E; Revel L; Serradell N; Rosa E Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809 [TBL] [Abstract][Full Text] [Related]
30. Pharma industry in India. Sundaram VM Drug News Perspect; 2008; 21(1):59-63. PubMed ID: 18301810 [TBL] [Abstract][Full Text] [Related]
31. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products. Becker C Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428 [TBL] [Abstract][Full Text] [Related]
33. Generics battle brand names over mortality of drug patents. Betz R J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008 [No Abstract] [Full Text] [Related]
34. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry. Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030 [TBL] [Abstract][Full Text] [Related]
35. [Free trade agreements make the drugs more expensive]. Jeppsson A Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499 [No Abstract] [Full Text] [Related]
36. Are patent expirations the answer to improving patient adherence? Klepser DG Am J Manag Care; 2008 Dec; 14(12):787-8. PubMed ID: 19067495 [No Abstract] [Full Text] [Related]
38. [Patients, patents and profits]. Roland PC Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741 [No Abstract] [Full Text] [Related]
39. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era. Rai AK Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845 [TBL] [Abstract][Full Text] [Related]